Who
Scott W. Morrison
Director
Company insider
Files Form 4 as: Director, Tarsus Pharmaceuticals; Director, Zai Lab; Director, IDEAYA Biosciences; Director, Vera Therapeutics; Director, Corvus Pharmaceuticals; Director, Global Blood Therapeutics; Director, Audentes Therapeutics.
In numbers
- Trades disclosed
- 101
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $860K
- Companies
- 7
- Companies where not an officer
- 7
- First trade
- 4 Jan 2016
- Last trade
- 25 Jun 2026
- Last filed
- 29 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 25 Jun 2026filed 29 Jun 2026 | TARS Tarsus Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,837 at $0.00 | filing |
| 25 Jun 2026filed 29 Jun 2026 | TARS Tarsus Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,417 at $0.00 | filing |
| 25 Jun 2026filed 29 Jun 2026 | TARS Tarsus Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,837 at $0.00 | filing |
| 25 Jun 2026filed 29 Jun 2026 | TARS Tarsus Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,417 at $0.00 | filing |
| 17 Jun 2026filed 22 Jun 2026 | ZLAB Zai LabBiotechnology | SEC FORM 4 Code A | —22,371 at $0.00 | filing |
| 17 Jun 2026filed 22 Jun 2026 | ZLAB Zai LabBiotechnology | SEC FORM 4 Code A | —22,371 at $0.00 | filing |
| 16 Jun 2026filed 18 Jun 2026 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 16 Jun 2026filed 18 Jun 2026 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 12 Jun 2026filed 16 Jun 2026 | TARS Tarsus PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —2,954 | filing |
| 12 Jun 2026filed 16 Jun 2026 | TARS Tarsus Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,954 at $0.00 | filing |
| 12 Jun 2026filed 16 Jun 2026 | TARS Tarsus Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,954 at $0.00 | filing |
| 12 Jun 2026filed 16 Jun 2026 | TARS Tarsus PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —2,954 | filing |
| 21 May 2026filed 26 May 2026 | VERA Vera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —17,084 at $0.00 | filing |
| 21 May 2026filed 26 May 2026 | VERA Vera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —17,084 at $0.00 | filing |
| 15 Sep 2025filed 16 Sep 2025 | TARS Tarsus Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,334 at $0.00 | filing |
| 15 Sep 2025filed 16 Sep 2025 | TARS Tarsus PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —1,334 | filing |
| 24 Jun 2025filed 26 Jun 2025 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 18 Jun 2025filed 23 Jun 2025 | ZLAB Zai LabBiotechnology | SEC FORM 4 Code A | —10,831 at $0.00 | filing |
| 13 Jun 2025filed 16 Jun 2025 | TARS Tarsus Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,350 at $0.00 | filing |
| 13 Jun 2025filed 16 Jun 2025 | TARS Tarsus PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —3,350 | filing |
News
No headline names them, or the companies they trade most, lately.